Study on the Effect of Selenium Supplementation on the Structure and Function of Autoimmune Thyroiditis

NCT04942769 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-07-16

No results posted yet for this study

Summary

To evaluate the effects of exogenous selenium supplementation on autoimmune thyroiditis.

Conditions

  • Selenium

Interventions

DRUG

Selenium

selenium 100ug ,take it orally twice daily

Sponsors & Collaborators

  • Beijing Chao Yang Hospital

    lead OTHER

Principal Investigators

  • Guang Wang · Beijing Chao Yang Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-20
Primary Completion
2021-07-30
Completion
2021-10-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04942769 on ClinicalTrials.gov